Molly Reissmann, MD
Urology · High Point, NCNPI 1053843334
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Teleflex LLC accounts for 72.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $1,100 and has fallen 93.2% since, to $74 in 2025. That places this record below the midpoint for urology clinicians in NC, where the typical reported total is $2,562.
Across 28 payments — averaging $58.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$1K
- Boston Scientific$157
- C. R. Bard, Inc. & Subsidiaries$154
- Johnson & Johnson$65
- Procept Biorobotics Corporation$33
- Ferring Pharmaceuticals Inc.$17
- plus $28 from 2 others
What the payments were for
- Speaking & faculty fees$16910%
- Travel & lodging$67841%
- Food & beverage$79248%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 13 | $1,184 |
| Boston Scientific | 3 | $157 |
| C. R. Bard, Inc. & Subsidiaries | 5 | $154 |
| Johnson & Johnson | 3 | $65 |
| Procept Biorobotics Corporation | 1 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| BD | 1 | $15 |
| Photocure Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$806
- UroLift System$123
- SpaceOAR VUE System - 10mL$121
How this compares
$1,639 in reported general payments places this provider in the 35th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 317 | $204,378 |
| GemtesaVibegron | 79 | $48,729 |
| Trospium Chloride | 100 | $7,153 |
| Estradiol | 81 | $6,408 |
| Tamsulosin Hcl | 446 | $5,715 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 139 | $4,359 |
| Oxybutynin Chloride ErOxybutynin Chloride | 250 | $3,746 |
| Finasteride | 293 | $2,957 |
| Potassium Citrate ErPotassium Citrate | 23 | $2,297 |
| Solifenacin Succinate | 70 | $1,553 |
| Cephalexin | 48 | $929 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 51 | $859 |
| Testosterone Cypionate | 25 | $676 |
| Methenamine Hippurate | 11 | $572 |
| Dutasteride | 16 | $381 |
Paid to pharmacies, not to this prescriber.
Other urology in High Point
- Robert LippittSmithfield$11.4M
- Michael KennellyCharlotte$1.3M
- John KasparRaleigh$1.1M
- Judd MoulDurham$1M
- Daniel GeorgeDurham$1M
- Scott MacdiarmidGreensboro$774K
- Glenn PremingerDurham$736K
- Michael LipkinDurham$293K
- Culley CarsonChapel Hill$275K
- Aaron LentzRaleigh$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.